JP2024539079A5 - - Google Patents
Info
- Publication number
- JP2024539079A5 JP2024539079A5 JP2024523266A JP2024523266A JP2024539079A5 JP 2024539079 A5 JP2024539079 A5 JP 2024539079A5 JP 2024523266 A JP2024523266 A JP 2024523266A JP 2024523266 A JP2024523266 A JP 2024523266A JP 2024539079 A5 JP2024539079 A5 JP 2024539079A5
- Authority
- JP
- Japan
- Prior art keywords
- binding molecule
- sequence
- amino acid
- nucleic acid
- car
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2114938.0A GB202114938D0 (en) | 2021-10-19 | 2021-10-19 | Her2 variant car |
| GB2114938.0 | 2021-10-19 | ||
| PCT/EP2022/079110 WO2023067007A1 (en) | 2021-10-19 | 2022-10-19 | Her2 variant car |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539079A JP2024539079A (ja) | 2024-10-28 |
| JP2024539079A5 true JP2024539079A5 (https=) | 2025-10-10 |
Family
ID=78718395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523266A Pending JP2024539079A (ja) | 2021-10-19 | 2022-10-19 | Ｈｅｒ２バリアントｃａｒ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240398949A1 (https=) |
| EP (1) | EP4419133A1 (https=) |
| JP (1) | JP2024539079A (https=) |
| KR (1) | KR20240099303A (https=) |
| CN (1) | CN118382455A (https=) |
| GB (1) | GB202114938D0 (https=) |
| WO (1) | WO2023067007A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025147472A1 (en) * | 2024-01-02 | 2025-07-10 | Phanes Therapeutics, Inc. | Anti-611-ctf p95her2 antibodies and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3915576A1 (en) * | 2020-05-28 | 2021-12-01 | Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron | Chimeric antigen receptors specific for p95her2 and uses thereof |
-
2021
- 2021-10-19 GB GBGB2114938.0A patent/GB202114938D0/en not_active Ceased
-
2022
- 2022-10-19 EP EP22808985.0A patent/EP4419133A1/en active Pending
- 2022-10-19 JP JP2024523266A patent/JP2024539079A/ja active Pending
- 2022-10-19 US US18/698,327 patent/US20240398949A1/en active Pending
- 2022-10-19 WO PCT/EP2022/079110 patent/WO2023067007A1/en not_active Ceased
- 2022-10-19 CN CN202280081682.6A patent/CN118382455A/zh active Pending
- 2022-10-19 KR KR1020247016436A patent/KR20240099303A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7150880B2 (ja) | 抗－ｂ７－ｈ３抗体およびその用途 | |
| JP7295146B2 (ja) | 抗－ｒｏｒ１抗体およびその用途 | |
| JP7000660B2 (ja) | Ｒｏｒ１抗体組成物及び関連の方法 | |
| CN109843927B (zh) | 抗b7-h3抗体、其抗原结合片段及其医药用途 | |
| JP6606505B2 (ja) | 抗ＳＩＲＰα抗体および二重特異性マクロファージ増強抗体 | |
| JP2026001061A (ja) | 抗ｄｌｌ３キメラ抗原受容体及びその使用 | |
| JP2021526816A (ja) | Ｄｌｌ３−ｃｄ３二重特異性抗体 | |
| JP2019116474A5 (https=) | ||
| JP2020525032A5 (https=) | ||
| AU2018218753A1 (en) | Anti-GPRC5D antibody and molecule containing same | |
| JP7820383B2 (ja) | グリピカン－３およびｔ細胞受容体を標的とする免疫グロブリン単一可変ドメインを含むポリペプチド | |
| JP2018532383A5 (https=) | ||
| JP2019527553A5 (https=) | ||
| WO2018137576A1 (zh) | 抗pd-1单克隆抗体及其制备方法和应用 | |
| JP2019513370A5 (https=) | ||
| JP2022542543A5 (https=) | ||
| KR20220012313A (ko) | 항-ror1/항-cd3 이중특이적 결합 분자 | |
| CA3196809A1 (en) | Combination treatment | |
| EP3405494A1 (en) | Ror2 antibody compositions and related methods | |
| JP2021521793A5 (https=) | ||
| CN108948194B (zh) | 一种新的ctla-4单克隆抗体 | |
| WO2017072366A1 (en) | Anti-mesothelin antibodies | |
| JP7821159B2 (ja) | Ｂｃｍａと結合する単一可変ドメイン及び抗原結合分子 | |
| JP2018522888A5 (https=) | ||
| JP2024001073A5 (https=) |